does surest cover glp 1 MCT2D MCT2D | 2023 Updates to

GLP-1 receptor agonists, such as Ozempic (semaglutide), have gained significant attention in recent years for their impressive weight loss results

In crude analyses, GLP-1 receptor agonist use was associated with an increased incidence of suicidality compared with DPP-4 inhibitors (crude incidence rates 3.9 v 1.8 per 1000 person years, respectively

Learn why the FDA banned compounded GLP-1s, what it means for your safety, and how to find trustworthy, FDA-approved weight loss medications.

All-Inclusive pricing, no hidden fees

Clear communication and transparency between distributors and consumers will play a critical role in supporting informed decision-making and maintaining trust as these therapies become more widely available